Pharmaceutical Power Plays: Why Big Pharma Is Looking Eastward
American pharmaceutical companies are increasingly partnering with Chinese firms to tap into China’s growing drug market. Lucrative deals, sometimes involving upfront payments
The Unveiled Strategies Behind Amarin’s VASCEPA Global Expansion
Amarin is strategically expanding the global reach of VASCEPA and its European counterpart, VAZKEPA, targeting cardiovascular health improvement. Entering 2024, Amarin displays
Unlocking the Secret Formula: Merck & Co. Emerges as the Alpha ‘Doberman of the Dow’
The Dobermans of the Dow strategy refines the traditional Dogs of the Dow by focusing on Return on Equity (ROE) and Free
Arrowhead Pharmaceuticals Faces Setback as Exciting Kidney Treatment Progresses
Arrowhead Pharmaceuticals experienced a stock market decline followng mixed reactions to its clinical trial outcomes. ARO-C3 is an RNA interference therapeutic targeting
Latest Posts
